Browsing by Subject "Multidrug resistance"
Now showing items 1-3 of 3
-
The creation of selenium nanoparticles decorated with troxerutin and their ability to adapt to the tumour microenvironment have therapeutic implications for triple-negative breast cancer
(Royal Society of Chemistry, 2023-02-09)Despite advancements in treatment, managing aggressive types of breast cancer, particularly Triple Negative Breast Cancer (TNBC), remains a daunting task. Newer chemotherapeutics enhance the multidrug resistance in cancer ... -
Natural products as multidrug resistance modulators in cancer
(Elsevier, 2019)Cancer is a prominent cause of death globally. Currently, many drugs that are in clinical practice are having a high prevalence of side effect and multidrug resistance. Risk of tumors acquiring resistance to chemotherapy ... -
Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review
(Springer, 2022-02-07)Imatinib, nilotinib, dasatinib, bosutinib, ponatinib, and asciminib are FDA-approved tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML), each of which has a specific pharmacological profile. Asciminib has ...